Key COVID-19 Studies Influencing My Practice Following IDWeek 2022—Audio Recap


Manage episode 347457799 series 2884624
由Player FM以及我们的用户群所搜索的Clinical Care Options, LLC and Clinical Care Options — 版权由出版商所拥有,而不是Player FM,音频直接从出版商的伺服器串流. 点击订阅按钮以查看Player FM更新,或粘贴收取点链接到其他播客应用程序里。

In this episode, Princy N. Kumar, MD, and Paul E. Sax, MD, discuss new COVID-19 data from IDWeek 2022, including:

  • COVID-19 vaccines, including omicron BA.1 bivalent booster
  • Risk factors for breakthrough COVID-19 infections
  • COVID-19 diagnostics, including digital droplet PCR
  • COVID-19 therapeutics, including:
    • Nirmatrelvir plus ritonavir
    • Tixagevimab plus cilgavimab
    • Baricitinib
    • Tocilizumab
    • Inhaled interferon β-1a
  • COVID-19 therapeutics and outcomes in patients with immunocompromise
  • Long COVID

Princy N. Kumar, MD, FIDSA, MACP
Professor of Medicine and Microbiology
Chief, Division of Infectious Diseases and Travel Medicine
Senior Associate Dean of Students
Georgetown University School of Medicine
Washington, DC

Paul E. Sax, MD
Clinical Director
HIV Program and Division of Infectious Diseases
Brigham and Women’s Hospital
Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Follow along with the downloadable slideset at:

Link to full program: